|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn560762795 |
003 |
OCoLC |
005 |
20231117032924.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100318s1982 enka o 000 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d UIU
|d OCLCF
|d E7B
|d N$T
|d YDXCP
|d EBLCP
|d OCLCQ
|d MERUC
|d OCLCO
|d OCLCQ
|d STF
|d UKAHL
|d OCLCQ
|d OCLCO
|d OCLCA
|d VLY
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 896795709
|a 907118282
|a 974614079
|a 974661897
|a 1100972694
|a 1153493926
|a 1162285305
|a 1397440468
|
020 |
|
|
|a 9781483191935
|q (electronic bk.)
|
020 |
|
|
|a 1483191931
|q (electronic bk.)
|
020 |
|
|
|z 040700212X
|
020 |
|
|
|z 9780407002128
|
035 |
|
|
|a (OCoLC)560762795
|z (OCoLC)896795709
|z (OCoLC)907118282
|z (OCoLC)974614079
|z (OCoLC)974661897
|z (OCoLC)1100972694
|z (OCoLC)1153493926
|z (OCoLC)1162285305
|z (OCoLC)1397440468
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a RM315
|
060 |
|
4 |
|a QV 77
|b D794 1982
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.89/18
|2 19
|
082 |
0 |
4 |
|a 615/.78
|2 19
|
245 |
0 |
0 |
|a Drugs in psychiatric practice /
|c edited by Peter J. Tyrer.
|
260 |
|
|
|a London ;
|a Boston :
|b Butterworths,
|c 1982.
|
300 |
|
|
|a 1 online resource (xii, 442 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a ReferencesChapter 6. Antianxiety drugs; Generalized central anxiolytics (sedative drugs); Specific central anxiolytics (ataractic drugs); Combined preparations including antianxiety drugs; Peripheral anxiolytics; Comparison of antianxiety drugs; References; Chapter 7. Tricyclic antidepressants; Introduction; Pharmacology; Pharmacokinetics; Clinical use; Introduction of amitriptyline; Other tricyclic antidepressant drugs; Comparisons between tricyclic drugs and other antidepressive treatments; Tricyclic drugs in the treatment of enuresis; General topics concerning the tricyclic drugs.
|
505 |
0 |
|
|a Front Cover; Drugs in Psychiatric Practice; Copyright Page; Preface; Contributors; Table of Contents; Introduction; References; Chapter 1. Classification of psychotropic drugs; What is a psychotropic drug?; Types of classification; Classification of drugs used in this book; References; Chapter 2. Pharmacokinetics and drug metabolismbasic principles; Definitions and basic principles in pharmacokinetics; Multiple administration; Absorption; Protein binding and distribution; Metabolism; Excretion; Pharmacokinetics and pharmacological effect; Conclusions; References.
|
505 |
8 |
|
|a Chapter 3. Evaluation of psychotropic drugsAnimal studies; Experimental studies in volunteers; Experimental studies in patients; Early clinical trials; Marketing; Early and late clinical evaluation; References; Chapter 4. Antischizophrenic drugs; Introduction; Nomenclature; Unconventional chemotherapy; Pharmacology; Non-DA-related pharmacology; Pharmacokinetics; Clinical efficacy; Unwanted effects; References; Chapter 5. Antiparkinsonian and antidyskinetic drugs; Introduction; Pathophysiology of neuroleptic-induced movement disorders; Drug treatment of neuroleptic-induced movement disorders.
|
505 |
8 |
|
|a Unwanted effectsReferences; Chapter 8. New generation of antidepressants; Tricyclic antidepressants; MAO inhibitors; Maprotiline (Ludiomil); Mianserin (Bolvidon, Norval); Flupenthixol (Fluanxol); Nomifensine (Merital); Trazodone (Molipaxin); Zimelidine; Comments; Summary; References; Chapter 9. Monoamine oxidase inhibitors and amine precursors; Pharmacology; Pharmacokinetics; Dosage and clinical response; Unwanted effects; Individual monoamine oxidase inhibitors; Main clinical indications for MAOIs; Amine precursors; Summary; References; Chapter 10. Lithium carbonate.
|
505 |
8 |
|
|a Introduction and historical aspectsPharmacology; Pharmacokinetics; Determination of lithium concentration; Lithium preparations; Clinical use; Treatment of depression with lithium; Lithium and schizoaffective disorders; Lithium and other conditions; Unwanted effects; Drug interactions; Unwanted and toxic effects of lithium; Acknowledgements; References; Chapter 11. Psychostimulants; Introduction; Pharmacology; Pharmacokinetics; Clinical efficacy; Methylphenidate; Other psychostimulants; Drug interactions; References; Chapter 12. Drugs of dependence; Controlled drugs; Opiate drugs.
|
520 |
|
|
|a Drugs in Psychiatric Practice present a comprehensive examination of the drug treatment in psychiatry. It discusses certain ways in which drugs behaved. It addresses the advances in pharmacology and the basis of prescription. Some of the topics covered in the book are the classification of psychotropic drugs; basic principles of pharmacokinetics and drug metabolism; anti-schizophrenic drugs; evaluation of psychotropic drugs; unconventional chemotherapy; anti-parkinsonian and anti-dyskinetic drugs; introduction of amitriptyline; and tricyclic antidepressants. The role of tricyclic drugs in the.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Psychotropic drugs.
|
650 |
|
0 |
|a Psychopharmacology.
|
650 |
|
2 |
|a Psychopharmacology
|0 (DNLM)D011600
|
650 |
|
2 |
|a Psychotropic Drugs
|x therapeutic use
|0 (DNLM)D011619Q000627
|
650 |
|
2 |
|a Psychotropic Drugs
|0 (DNLM)D011619
|
650 |
|
6 |
|a Psychopharmacologie.
|0 (CaQQLa)201-0020955
|
650 |
|
6 |
|a Psychotropes.
|0 (CaQQLa)201-0001454
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Psychopharmacology
|2 fast
|0 (OCoLC)fst01081659
|
650 |
|
7 |
|a Psychotropic drugs
|2 fast
|0 (OCoLC)fst01081826
|
653 |
|
|
|a Psychotropic drugs
|
700 |
1 |
|
|a Tyrer, Peter J.
|
776 |
0 |
8 |
|i Print version:
|t Drugs in psychiatric practice.
|d London ; Boston : Butterworths, 1982
|w (OCoLC)11043852
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780407002128
|z Texto completo
|